Welcome to ebovac2

The EBOVAC2 project is one of 8 projects funded under IMI Ebola+ programme that was launched in response to the Ebola virus disease outbreak. The project aims to assess the safety and efficacy of a novel prime boost preventive vaccine regimen against Ebola Virus Disease (EVD).

To expedite the development of the vaccine regimen, Phase 2 and Phase 3 trials will be carried out in parallel and therefore coordinated by two separate teams within EBOVAC1 (Phase 1 trials and Phase 2B large scale safety and immunogenicity study) and EBOVAC2 (Phase 2 trial) projects. Find out more about Phase 2.

© Janssen

 

Between them, the EBOVAC projects will assess, through phase 1, 2 trials and Phase 2B study in Europe and Africa, the safety and tolerability of the vaccine regimen in response to the urgent public health need raised by the Ebola epidemic.